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The importance of gut microbiota
in mediating the effect of NOD2
defects in inflammatory bowel
disease
Gerhard Rogler
It is well accepted that genetic factors
contribute to the pathogenesis of Crohn’s
disease. Susceptibility genes have been
identified; however, the exact mechanisms
of how those risk genes contribute to
the pathogenesis of Crohn’s disease
still remain to be elucidated. Therefore,
insights such as those provided by
Barreau and co-workers from the group of
Jean-Pierre Hugot in this issue of Gut1
(see page 207) are important and helpful.
The proof of the ‘genetic susceptibility
concept’ for Crohn’s disease was achieved
in 2001 by Hugot and others by the
finding that single nucleotide polyp-
morphisms (SNPs) in the NOD2 gene are
significantly associated with the risk of
developing Crohn’s disease.2e4 About
20e40% of all patients in Europe and
North Americaddepending on the genetic
backgrounddcarry variants of NOD2 in
contrast to 10e15% in the healthy popu-
lation. Three major NOD2 genetic variants
have been associated with Crohn’s disease
in Caucasians in several independent
studies. In contrast, NOD2 variants are
irrelevant in the Asian population and do
not play a role in the pathogenesis of
Crohn’s disease in Japan or China.5 6
The function of Nod2 has been inten-
sively investigated since then. Muramyl
dipeptide (MurNAc-L-Ala-D-isoGln, MDP),
a component of the bacterial wall derived
from peptidoglycan, was found to be the
major ligand for NOD2.7 8 Interestingly,
MDP was long known to be the essential
structure in Freund’s adjuvans, important
for vaccination. Nod2 protein variants
associated with susceptibility to Crohn’s
disease seem to be deficient in their recog-
nition of MDP.8 Subsequently, they have
been regarded as ‘loss of function’
mutations.
Nod2 protein expression was mainly
found in mucosal macrophages which
represent a central component of the innate
immune system. They are capable of
phagocytosis and destroy pathogens. They
also react to bacteria by secreting cytokines
and toxic oxygen radicals.9 A role for the
epithelial Paneth cells in NOD2-related
Crohn’s disease pathophysiology was
supported by the finding that these cells
were mostly prominent, expressing Nod2
in normal and Crohn’s disease mucosa.10 11
In inflamed mucosa from patients with
Crohn’s disease increased Nod2 expression
was found in intestinal epithelial cells
(IECs) and macrophages9 12 but not in
Tcells. This raised the question of how the
NOD2 variants could finally lead to
a ‘Tcell disease’.
NOD2 is a member of a superfamily of
genes, the nucleotide-binding site and
leucine-rich repeat (NBS-LRR) proteins,
which are involved in intracellular recogni-
tion of microbes and their products.13 NBS-
LRR proteins play an important role in the
innate immune system as pattern recogni-
tion receptors (PRRs). The microbial
patterns recognised by PRRs are evolu-
tionarily highly conserved. Already plants
have an innate immune system of PRRs
recognising the same patterns of microbes
as compared to humans. As Nod2 is an
important intracellular sensor of bacterial
wall products it was assumed that it would
not only play a role in Crohn’s disease
pathophysiology. Subsequently, a high
impact of NOD2 variants on disease
development, pathogenesis and even
disease-associated mortality could also be
demonstrated in graft versus host disease
(GvHD) after allogenic bone marrow
transplantation.14 15 GvHD is associated
with increased intestinal permeability.
Experimental models indicate the primacy
of gastrointestinal damage; conditioning-
related damage of the intestinal epithelium
results in bacterial translocation followed
by increased cytokine release by macro-
phages and finally T cell activation. The
incidence of severe GvHD (and associated
gastrointestinal GvHD) increases from 18%
in Stem Cell Transplantation (SCT) donor/
recipient pairs without any NOD2 variant
to 37% in pairs with either donor or recip-
ient mutations with a subsequent increase
of treatment related mortality (TRM) from
33% to 60%.14 15
Again the question arises from those data
how a reduced recognition of invading
bacteria at the intestinal barrier and
subsequent reduced activation of the innate
immune system may cause chronic
mucosal inflammation. How can a reduced
inflammatory response finally lead to an
increased and uncontrolled inflammatory
response? Do bacteria play an essential
role for this? Barreau and co-workers1 now
provide some important answers. They
show that both anti-CD4+ and anti-
interferon g (anti-IFNg) antibodies abro-
gate the increased bacterial translocation
found in Peyer ’s patches (PPs) of Nod2/
mice. This indicates that CD4+ Tcells are
able to influence epithelial functions such
as trans- (and para-cellular?) permeability.
However, obviously this part of the cross-
talk between epithelium and T cells must
be secondary to the primary hit in which T
cells are recruited and the Tcell function is
altered. Bacteria certainly are involved in
this so far unknown primary event as
antibiotic treatment in the Nod2/
mouse could reverse the mucosal pheno-
type. Barreu and co-workers subsequently
hypothesise that the ileal flora promotes
recruitment and activation of CD4+ cells
inside the PPs. These cells secrete cytokines
such as IFNgwhich causes upregulation of
tumour necrosis factor (TNF) receptor2
expression in the epithelium. This could be
followed by increased permeability of the
epithelium (transcellular or paracellular:
TNF has been shown to upregulate
expression of the pore-forming tight junc-
tion protein claudin-2) and further uptake
of bacteria into the mucosa. That again
would lead to increased recruitment of
CD4+ cells and close a circle leading to
chronification of inflammation.
While this concept is attractive, several
questions remain open. Why is there an
initially increased recruitment of CD4+
cells into the PP region caused by bacteria?
How can it be explained that in human
GvHD the relative amount of CD4+ cells
in the colonic lamina propria is signifi-
cantly reduced in GvHD patients with
NOD2 variants as compared to patients
with NOD2 WT.16 The group of Jean-
Pierre Hugot has started to characterise the
Nod2snp13/snp13 mouse model and found an
increased number of PPs and increased
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number of immune cells per PP as well as
increased translocation of Escherichia coli in
Ussing chamber experiments similar to the
NOD2/ mice. These first experiments
are mentioned in the manuscript by
Barreau et al.1 We look forward to a more
detailed characterisation of this mouse
model with the assays the group has
established to obtain more answers on this
important aspect of Nod2 function and
the initiation of inflammation in patients
with Crohn’s disease.
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The new ‘connexin’ to the
pathogenesis of E coli diarrhoea
Alastair J M Watson
Infectious diarrhoea is a major cause of
morbidity and mortality causing 1.5
million deaths worldwide in 2005.1 Thus
the pathobiology of diarrhoea is of
considerable interest. However, despite
considerable research over the last
50 years, significant gaps remain in our
knowledge of the pathogenic diarrhoea
mechanisms of specific microorganisms.
Diarrhoea can be regarded simply as an
excess of water in faeces. The healthy
adult intestine must absorb approxi-
mately 7 litres per 24 h to produce
a normal stool. Failure of absorption or,
alternatively, secretion of water into the
intestine or a combination of the two will
cause diarrhoea.
Vibrio cholerae or enterotoxogenic Escher-
ichia coli (ETEC) secrete toxins which cause
the accumulation of the second messenger
cyclic AMP or, in the case of ETEC, cyclic
GMP in intestinal epithelial cells. These
second messengers cause secretion of water
into the intestinal lumen through a couple of
mechanisms. Secretion occurs predomi-
nately in the intestinal crypts. They can
directly open an anion channel on the apical
membrane of epithelial cells called cystic
fibrosis transmembrane conductance regu-
lator (CFTR) allowing the efflux of chloride
ions resulting in osmotic gradients that pull
water into the intestinal lumen; a process
called electrogenic chloride secretion.2 They
also activate a neural reflex within the
intestinal wall releasing the neurotransmitter
vasoactive intestinal polypeptide (VIP)
near epithelial cells, again causing accu-
mulation of cAMP in epithelial cells and
electrogenic chloride secretion.3 4 On villi,
cholera toxin and E coli STa toxin inhibit
the process NaCl absorption, called elec-
troneutral NaCl absorption, which is
mediated by the coupled action of Na/H
and anion exchangers. The mechanism of
inhibition of these exchangers is not fully
understood but involves at least nine
regulatory proteins.4
The attaching and effacing (A/E) path-
ogens enterohemorrhagic E coli (EHEC),
enteropathogenic E coli (EPEC) and mouse
A/E pathogen Citrobacter rodentium do not
cause secretion as described above but
rather trigger changes in the structure of
epithelial cells and tight junctions between
epithelial cells which increases the perme-
ability of intestinal epithelium to water.
In these circumstances hydrostatic pres-
sure in blood vessels and lymphatics will
drive fluid, protein and cells into the
intestinal lumen.5 6 Induction of inflam-
mation by A/E pathogens with the release
of TNF will further exacerbate this
exudation through an increase in vascular
permeability.7
Work over the last decade has shown
that A/E pathogens cause a profound
remodelling of the actin cytoskeleton of
intestinal epithelial cells causing the
formation of a characteristic pedestal on
their apical membrane. This is achieved by
the bacteria injecting a number of effector
proteins through a syringe-like structure
called a Type III secretory system which
flatten the microvilli of the apical
membrane and raise the pedestal upon
which individual bacteria reside.8 9 The
function of the pedestal may be to inhibit
phagocytosis of bacteria but it also has the
consequence of reducing the surface area
available for absorption. The injected
bacterial proteins EspF, EspG and Map
disrupt the tight junctions by causing
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